FDA Appropves Risankizumab For Crohn’s Disease

Press/Media

Period	17 Jun 2022

Media coverage

Title	FDA Appropves Risankizumab For Crohn’s Disease
Media name/outlet	Consultant Live
Country/Territory	United States
Date	17/06/22
URL	https://www.consultantlive.com/view/fda-appropves-risankizumab-crohns-disease
Persons	Marla Dubinsky

Title	FDA Appropves Risankizumab For Crohn’s Disease
Media name/outlet	HCPLive
Country/Territory	United States
Date	17/06/22
URL	https://www.hcplive.com/view/fda-appropves-risankizumab-crohns-disease
Persons	Marla Dubinsky